Form 4 for PTHS Pelthos Therapeutics Inc.

Accepted 2024-09-16 00:00:00 ET · period of report 2024-09-12 · accession 0001753926-24-001576 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2024-09-16	2024-09-12+	PTHS	Francis Knuettel II	CEO, Pres, CFO, Treas, Secty	P - Purchase	$0.97	+5,200	547.7K	+1.0%	+$5,044

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-09-12	P	A	1,700	$0.97	544,210	I By Lara Knuettel Revocable Trust	—	—	(F1) This transaction is being reported to reflect the purchase of these shares by the Lara Knuettel Revocable Trust, of which the Reporting Person is co-trustee and has individual dispositive power. This price represents the weighted average price of the shares purchased ranging from $0.93 to $0.98 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
2	Common	Common Stock	2024-09-13	P	A	3,500	$0.97	547,710	I By Lara Knuettel Revocable Trust	—	—	(F2) This transaction is being reported to reflect the purchase of these shares by the Lara Knuettel Revocable Trust, of which the Reporting Person is co-trustee and has individual dispositive power. This price represents the weighted average price of the shares purchased ranging from $0.94 to $0.98 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.